Company: CWAN
Filing Date: 2025-04-02
Form Type: 425
Source: 0001193125-25-071387
Chunk: 5

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-04-02
Form: 425
Chunk 5
---
 2025 |     | By: |     | Clearwater Analytics Holdings, Inc. 
 /s/ Jim Cox                         |
|:--------------------|:----|:----|:----|:------------------------------------|
|                     |     |     |     | Jim Cox, Chief Financial Officer    |

Exhibit 99.1 FOR IMMEDIATE RELEASE Clearwater Analytics and Enfusion Announce Election Deadline for Enfusion Shareholders to Elect Form of Merger Consideration BOISE, Idaho, and CHICAGO, Illinois – April 2, 2025— Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced that the deadline for Enfusion shareholders of record to elect the form of merger consideration (the “Merger Consideration”) they wish to receive in connection with Clearwater’s acquisition of Enfusion (the “Transaction”) is 5:00 p.m. Eastern Time on April 16, 2025 (such deadline, as it may be extended, the “Election Deadline”). Enfusion shareholders who hold shares through a bank, broker or other nominee may be subject to an earlier election deadline and must carefully review and properly complete any election materials they received from their bank, broker or other nominee regarding how to make an election. The parties expect to close the Transaction on or about April 21, 2025, subject to the approval of the Transaction by Enfusion shareholders and the satisfaction or waiver of other customary closing conditions. The election materials necessary for Enfusion shareholders of record to make an election as to the form of Merger Consideration they wish to receive have been sent to holders of record of Enfusion common stock as of March 20, 2025. Enfusion shareholders of record wishing to make an election must deliver properly completed election materials to Computershare Trust Company, N.A. by the Election Deadline. As previously disclosed, on January 10, 2025, Enfusion, Clearwater, Enfusion Ltd. LLC (“Enfusion OpCo”), Poseidon Acquirer, Inc., Poseidon Merger Sub I, Inc. and Poseidon Merger Sub II, LLC entered into an Agreement and Plan of Merger (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement and as further described in the election materials and in the parties’ definitive proxy statement/prospectus dated March 20, 2025, as supplemented by Supplement No. 1 thereto dated March